Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies

Systemic lupus erythematosus (SLE) and bullous pemphigoid (BP) are chronic autoimmune diseases in which B cells play an important pathogenic role in the different stages of the disease. B cell-targeted therapies have been suggested as a new rational approach for treating SLE. Rituximab (RTX), an ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Petricca, Luca, Gigante, Maria Rita, Paglionico, Annamaria, Costanzi, Stefano, Vischini, Gisella, Di Mario, Clara, Varriano, Valentina, Tanti, Giacomo, Tolusso, Barbara, Alivernini, Stefano, Grandaliano, Giuseppe, Ferraccioli, Gianfranco, Gremese, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657367/
https://www.ncbi.nlm.nih.gov/pubmed/33195302
http://dx.doi.org/10.3389/fmed.2020.553075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657367/
https://www.ncbi.nlm.nih.gov/pubmed/33195302
http://dx.doi.org/10.3389/fmed.2020.553075

Ejemplares similares